Feng Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Feng Lin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bosi Yuan
Department of Gastroenterology, Jinling Hospital, Jiangsu province, China
1 shared publication - Jianling Bai
Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, 140 Hanzhong Road, Nanjing, China
1 shared publication - Jie You
Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
1 shared publication - Ming-Hua Zheng
MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
1 shared publication - Mingqin Lu
The First Affiliated Hospital of Wenzhou Medical University
1 shared publication - Yong-Ping Chen
Wenzhou Med Coll, Dept Infect & Liver Dis, Affiliated Hosp 1, Liver Res Ctr, Wenzhou 325000, Peoples R China
1 shared publication
Latest Publications
- Open Access
- 14 February 2008
- Published by Springer Nature in BMC Gastroenterology
- Vol. 8 (1) , 6
Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography and benefit of pharmacological treatment is unclear. Although prophylactic use of corticosteroid for reduction of pancreatic injury after ERCP has been evaluated, discrepancy about beneficial effect of corticosteroid on pancreatic injury still exists. The aim of current study is to evaluate effectiveness and safety of corticosteroid in prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP).
- 14 February 2008
- Published by Springer Nature in BMC Gastroenterology
- Vol. 8 (1) , 6
Open AccessMeta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography and benefit of pharmacological treatment is unclear. Although prophylactic use of corticosteroid for reduction of pancreatic injury after ERCP has been evaluated, discrepancy about beneficial effect of corticosteroid on pancreatic injury still exists. The aim of current study is to evaluate effectiveness and safety of corticosteroid in prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP).